UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001210 |
|---|---|
| Receipt number | R000001475 |
| Scientific Title | Safety and Efficacy of Bortezomib inaddtion to Adriamycin and Intermediate-Dose Dexamethasone (iPAD) in Subjects with Relapse/Refractory Multiple Myeloma with Primary Therapies ; A PhaseI/II, Multicentre, Open-Label, Single-Arm Study |
| Date of disclosure of the study information | 2008/06/26 |
| Last modified on | 2018/05/14 16:34:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/06/26 09:52:22 | ||
| 2 | Update | 2008/12/26 11:47:51 | ||
| 3 | Update | 2010/06/28 18:55:38 | Recruitment status |
|
| 4 | Update | 2010/08/04 15:15:43 | Organization Division name Address |
|
| 5 | Update | 2011/04/09 12:06:13 | Recruitment status |
|
| 6 | Update | 2018/05/14 16:34:42 | TEL Name of primary person or sponsor Organization Nationality of Funding Organization Nationality of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
